Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 26
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Peptides ; 166: 171027, 2023 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-37245722

RESUMEN

The apelinergic system widely expressed and regulates hormone-enzyme secretion, motility, and protective mechanisms of the stomach. This system consists of the apelin receptor (APJ) and two peptides known as apela and apelin. The IR-induced experimental gastric ulcer model is a well-known and commonly used one that induces hypoxia and causes the release of proinflammatory cytokines. Expressions of apelin and its receptor APJ are induced by hypoxia and inflammation in the gastrointestinal tract. Apelin has been shown to affect angiogenesis positively, considered the most critical component of the healing process. Although it is known that apelin and AJP expressions are induced by inflammatory stimuli and hypoxia, stimulate endothelial cell proliferation and have a role in regenerative angiogenesis, no information or has been found in the literature regarding the role of APJ in the formation and healing of gastric mucosal lesions induced by I/R. So, we conducted a study to clarify the role of APJ in formation and healing mechanisms of IR-induced gastric lesions. Male Wistar rats were divided into five groups; control, sham-operated, IR, APJ antagonist treated-IR group (F13A+IR), and the healing groups. F13A was intravenously given to the animals. Gastric lesion index, mucosal blood flow, PGE2, NOx, 4-HNE-MDA, HO activity, and protein expressions of VEGF and HO-1 were measured. F13A application before the IR increased the mucosal injury, F13A application following the ischemia delayed the mucosal healing during the reperfusion period. Consequently, blocking apelin receptors may worsen gastric injury due to the IR and delay mucosal healing.


Asunto(s)
Hormonas Peptídicas , Úlcera Gástrica , Animales , Masculino , Ratas , Apelina/genética , Receptores de Apelina/genética , Receptores de Apelina/metabolismo , Péptidos y Proteínas de Señalización Intercelular/genética , Isquemia , Ratas Wistar , Receptores Acoplados a Proteínas G/genética , Receptores Acoplados a Proteínas G/metabolismo , Reperfusión , Úlcera Gástrica/tratamiento farmacológico
2.
Biotech Histochem ; 98(2): 132-139, 2023 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-36245360

RESUMEN

Nuclear factor-erythroid 2-related factor- 2 (Nrf2) is a nuclear transcription factor that facilitates transcription of genes for detoxification enzymes and antioxidant proteins. We investigated the distribution and expression of Nrf2 during the peri-implantation period. We detected Nrf2 in uteri of mice during estrus (control) and on days 1, 4, 5, 6 and 8 of pregnancy using immunohistochemistry, quantitative real-time polymerase chain reaction and western blotting. Nrf2 immunostaining was significantly greater on days 1, 5 and 6 of pregnancy compared to controls, and on days 4 and 8 of pregnancy; western blotting results were consistent with immunohistochemical observations. Nrf2 mRNA levels on days 5 and 8 were significantly higher than for control uteri. Increased expression of Nrf2 on days 1, 5 and 6 of pregnancy may be important for uterine receptivity, implantation and decidualization by protecting the developing embryo and uterus from the adverse effects of oxidative stress.


Asunto(s)
Implantación del Embrión , Factor 2 Relacionado con NF-E2 , Embarazo , Femenino , Ratones , Animales , Factor 2 Relacionado con NF-E2/genética , Factor 2 Relacionado con NF-E2/metabolismo , Útero/metabolismo , ARN Mensajero/metabolismo , Regulación de la Expresión Génica
3.
Tissue Cell ; 78: 101885, 2022 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-35940035

RESUMEN

The apelin/APJ system, which has a widespread distribution in the body, is involved in the regulation of physiological and pathophysiological mechanisms such as regulation of blood pressure, stress response, immunological activities, obesity, diabetes, inflammation, and neurodegenerative diseases. Apelin also undertakes various tasks in the digestive system such as cell proliferation, secretion of hormones (eg. cholecystokinin and histamine), modulation of gastric and pancreatic secretions, and motility response. Recent researchs have reported that apelin exerts gastroprotective effects by regulating the components of gastric mucosal barrier. Mucosal disorders that can develop in the stomach due to different reasons such as microbial infections, drug use, smoking habits, alcohol consumption, exposure to stress, pepsin, and acid affect a significant proportion of the human population in the world. This review discusses the role of apelin in the protective mechanisms of gastric mucosa against harmful effects.


Asunto(s)
Histamina , Pepsina A , Apelina , Colecistoquinina , Mucosa Gástrica , Humanos
4.
Can J Physiol Pharmacol ; 98(5): 282-295, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-31821012

RESUMEN

Apelin is a peptide that plays a role in physiological processes such as angiogenesis, apoptosis, and proliferation. The aim of this study was to investigate the role of capsaicin-sensitive afferent neurons and vagus in the effect of apelin against ischemia/reperfusion (I/R) injury. The experimental groups were (1) control, (2) I/R, (3) apelin + I/R, (4) vagotomy + I/R, (5) vagotomy + apelin + I/R, (6) capsaicin + I/R, (7) capsaicin + apelin + I/R, (8) lorglumide + I/R, and (9) lorglumide + apelin + I/R. To test the potential gastroprotective effect of apelin-13, apelin-13 (2 mg/kg i.v.) was administered just before both ischemia and reperfusion. A vagotomy was performed 1 week before I/R in the vagotomized groups; capsaicin (125 mg/kg s.c.) was administrated 2 weeks before I/R in the capsaicin-treated groups and lorglumide (5 mg/kg i.p.) was administered 30 min before I/R in the lorglumide-treated groups. After I/R, a variety parameters in gastric tissue were analyzed. cfos expression was determined in brainstem samples. In the I/R group, the lesion index, myeloperoxidase activity, lipid peroxidation, nitric oxide, and tumor necrosis factor-α increased, and mucosal blood flow, prostaglandin-E2, and calcitonin gene related peptide decreased. Apelin prevented the damaging effects of I/R and increased cfos expression in brainstem areas. Vagotomy, capsaicin, and lorglumide largely eliminated the gastroprotective effects of apelin-13. This study showed that sensory nerves and the vagus play regulatory roles in apelin-induced gastroprotection. Cholecystokinin may play a role in the effect of apelin through sensory neurons.


Asunto(s)
Péptidos y Proteínas de Señalización Intercelular/farmacología , Daño por Reperfusión/tratamiento farmacológico , Daño por Reperfusión/fisiopatología , Células Receptoras Sensoriales/efectos de los fármacos , Estómago/efectos de los fármacos , Estómago/inervación , Nervio Vago/efectos de los fármacos , Animales , Citoprotección/efectos de los fármacos , Dinoprostona/metabolismo , Relación Dosis-Respuesta a Droga , Masculino , Óxido Nítrico/metabolismo , Peroxidasa/metabolismo , Ratas , Ratas Wistar , Receptor de Colecistoquinina B/metabolismo , Daño por Reperfusión/metabolismo , Daño por Reperfusión/patología , Células Receptoras Sensoriales/patología , Nervio Vago/fisiopatología
5.
Tissue Cell ; 56: 41-51, 2019 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-30736903

RESUMEN

Parkinson's disease (PD) is a degenerative disorder of the human central and peripheral nervous systems. n-3 fatty acids docosahexaenoic acid (DHA, C22: 6n-3) and eicosapentaenoic acid (EPA) as well as apelin have anti-inflammatory effects in various cells. At the same time, apelin has anti-oxidative and anti-apoptotic effects. The study was conducted to determine the effect of DHA on the distribution of apelin and apelin receptor (APJ) in the central nervous system in 1-methyl-4-phenyl-1, 2, 3, 6 tetrahydropyridine (MPTP)-induced PD model. DHA treatment decreased the return time and total down time in the Parkinson group which were measured by pole test. Besides, the ambulatory activity, distance and total locomotor activity were increased by DHA in the PD model of animals. The time mice remained on the rotating rod mile was also significantly increased by DHA treatment in MPTP injected animals. The apelin expression in the pons of mice in the Parkinson, DHA and Parkinson + DHA groups were lower compared to the Control group. When apelin and apelin receptor expressions in cerebrum were examined, there was no statistically significant difference between the groups. When apelin receptor expression in cerebellum was examined, the difference between the Control and Parkinson + DHA, Parkinson and Parkinson + DHA, DHA and Parkinson + DHA groups were statistically significant. Apelin receptor expressions in pons of the Parkinson, DHA and Parkinson + DHA groups were lower compared to the Control group. Apelin protein levels of cerebellum and pons were found to be decreased in DHA group compare with Control group. In conclusion; DHA has been implicated in the expression of the apelin receptor and has reduced the expression of APJ receptor.


Asunto(s)
Receptores de Apelina/genética , Apelina/genética , Enfermedad de Parkinson/tratamiento farmacológico , Trastornos Parkinsonianos/tratamiento farmacológico , Animales , Modelos Animales de Enfermedad , Ácidos Docosahexaenoicos/administración & dosificación , Ácido Eicosapentaenoico/administración & dosificación , Regulación de la Expresión Génica , Humanos , Ratones , Sistema Nervioso/efectos de los fármacos , Fármacos Neuroprotectores/administración & dosificación , Enfermedad de Parkinson/genética , Enfermedad de Parkinson/patología , Trastornos Parkinsonianos/genética , Trastornos Parkinsonianos/patología
6.
Clin Exp Pharmacol Physiol ; 46(1): 29-39, 2019 01.
Artículo en Inglés | MEDLINE | ID: mdl-30225902

RESUMEN

Exposure to stress induces gastrointestinal (GI) dysmotility. In rodents, acute restraint stress (ARS) inhibits gastric emptying (GE) and intestinal transit (IT) via central and peripheral corticotropin-releasing factor (CRF)-mediated pathways. Peripherally administered apelin-13 was shown to inhibit GI motor functions; moreover, stress-induced upregulation of gastric apelin content was demonstrated in rats suggesting that peripheral apelin may mediate stress-induced alterations in GI motility. We investigated the role of endogenous peripheral apelin in stress-induced GI dysfunction. GE, IT and gastro-duodenal fasting motility were measured in non-stressed (NS), CRF-injected and ARS-loaded rats. CRF and apelin receptor antagonists astressin or F13A was administered before ARS or peripheral CRF injection. Apelin and APJ receptor expressions were determined using immunohistochemistry and quantified by qRT-PCR. Double immunofluorescence was performed for enteric neuronal apelin. GE and IT were delayed by CRF and ARS. ARS-induced changes were attenuated by F13A, whereas astressin was ineffective. CRF-induced alterations in GE and IT were restored completely by astressin, while they were diminished by F13A. Antral phase III-like contractions were disturbed following ARS which were preserved by preadministration of astressin, but not F13A. CRF impaired gastric and duodenal fasting contractions, while these changes were not altered by F13A. ARS increased apelin expression in stomach and duodenum. Apelin immunoreactivity was detected in mucosa, smooth muscles and myenteric plexi, whereas dense APJ receptor expression was observed within tunica muscularis. APJ receptor was downregulated in rats fasted overnight. These results suggest that enteric apelin acts as an inhibitor stress mediator in the postprandial state.


Asunto(s)
Apelina/administración & dosificación , Apelina/farmacología , Vaciamiento Gástrico/efectos de los fármacos , Tránsito Gastrointestinal/efectos de los fármacos , Estado Nutricional , Restricción Física/psicología , Estrés Fisiológico/fisiología , Animales , Apelina/genética , Apelina/metabolismo , Receptores de Apelina/genética , Receptores de Apelina/metabolismo , Hormona Liberadora de Corticotropina/farmacología , Duodeno/citología , Duodeno/efectos de los fármacos , Duodeno/fisiología , Ayuno/fisiología , Vaciamiento Gástrico/fisiología , Regulación de la Expresión Génica/efectos de los fármacos , Masculino , Fragmentos de Péptidos/farmacología , Transporte de Proteínas/efectos de los fármacos , ARN Mensajero/genética , Ratas , Ratas Wistar , Transducción de Señal/efectos de los fármacos , Estómago/citología , Estómago/efectos de los fármacos , Estómago/fisiología , Estrés Fisiológico/efectos de los fármacos
7.
J Physiol Sci ; 67(3): 373-385, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-27369695

RESUMEN

The objective of this study was to explore the role of apelin in the healing of gastric lesions induced by stress. Male Wistar rats were exposed to water immersion and restraint stress (WIRS) for 6 h with or without the apelin receptor antagonist F13A. The rats were killed on the 1st, 3rd, 5th or 10th day after the end of stress induction. Apelin and hypoxia-inducible factor-1α expression was increased on the 1st day after the end of stress exposure and was decreased daily thereafter. However, F13A retarded the healing of gastric lesions by preventing the improvement of mucosal blood flow, prostaglandin E2 production and vascular endothelial growth factor expression in rats exposed to WIRS. Additionally, F13A increased the gastric 4-hydroxynonenol + malondialdehyde content on the 1st and 3rd days after the end of stress induction but did not affect the change in gastric mucosal nitric oxide levels. In conclusion, apelin may be a regulatory protein involved in the healing mechanism of stress-induced gastric damage.


Asunto(s)
Deshidratación/metabolismo , Mucosa Gástrica/metabolismo , Inmersión/fisiopatología , Péptidos y Proteínas de Señalización Intercelular/metabolismo , Restricción Física/fisiología , Estrés Fisiológico/fisiología , Animales , Apelina , Deshidratación/fisiopatología , Mucosa Gástrica/fisiopatología , Subunidad alfa del Factor 1 Inducible por Hipoxia/metabolismo , Masculino , Malondialdehído/metabolismo , Óxido Nítrico/metabolismo , Ratas , Ratas Wistar , Estómago/fisiopatología , Factor A de Crecimiento Endotelial Vascular/metabolismo , Agua/metabolismo
8.
Peptides ; 87: 1-11, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-27829122

RESUMEN

Hypothalamic oxytocin (OXT) and arginine vasopressin (AVP) are known to act oppositely on hypothalamic-pituitary-adrenal (HPA) axis, stress response and gastrointestinal (GI) motility. In rodents, exposure to restraint stress (RS) delays gastric emptying (GE), however, repeated exposure to the same stressor (chronic homotypic stress (CHS)), the delayed GE is restored to basal level, while hypothalamic OXT is upregulated. In contrast, when rats are exposed to chronic heterotypic stress (CHeS), these adaptive changes are not observed. Although the involvement of central OXT in gastric motor adaptation is partly investigated, the role of hypothalamic AVP in CHeS-induced maladaptive paradigm is poorly understood. Using in-vivo brain microdialysis in rats, the changes OXT and AVP release from hypothalamus were monitored under basal non-stressed (NS) conditions and in rats exposed to acute stress (AS), CHS and CHeS. To investigate the involvement of central endogenous OXT or AVP in CHS-induced habituation and CHeS-induced maladaptation, chronic central administration of selective OXT receptor antagonist L-371257 and selective AVP V1b receptor antagonist SSR-149415 was performed daily. OXT was measured higher in AS and CHS group, but not in CHeS-loaded rats, whereas AVP significantly increased in rats exposed to AS and CHeS. Additionally, the response of the hypothalamic OXT- and AVP-producing cells was amplified following CHS and CHeS, respectively. In rats exposed to AS for 90min solid GE significantly delayed. The delayed-GE was completely restored to the basal level following CHS, however, it remained delayed in CHeS-loaded rats. The CHS-induced restoration was prevented by L-371257, whereas SSR-149415 abolished the CHeS-induced impaired GE. A significant correlation was observed between GE and (i) OXT in CHS-loaded rats (rho=0.61, p<0.05, positively), (ii) AVP in CHeS-loaded rats (rho=0.69, p<0.05, negatively). Under long term stressed conditions, the release of AVP and OXT from hypothalamus may vary depending on the content of the stressors. Central AVP appears to act oppositely to OXT by mediating CHeS-induced gastric motor maladaptation. Long term central AVP antagonism might be a pharmacological approach for the treatment of stress-related gastric motility disorders.


Asunto(s)
Arginina Vasopresina/metabolismo , Hormona Liberadora de Corticotropina/metabolismo , Vaciamiento Gástrico/efectos de los fármacos , Oxitocina/metabolismo , Animales , Antagonistas de los Receptores de Hormonas Antidiuréticas/administración & dosificación , Benzoxazinas/administración & dosificación , Encéfalo/metabolismo , Encéfalo/fisiología , Vaciamiento Gástrico/fisiología , Motilidad Gastrointestinal/efectos de los fármacos , Hipotálamo/metabolismo , Hipotálamo/fisiología , Indoles/administración & dosificación , Microdiálisis , Piperidinas/administración & dosificación , Sistema Hipófiso-Suprarrenal/metabolismo , Pirrolidinas/administración & dosificación , Ratas , Receptores de Oxitocina/antagonistas & inhibidores , Estrés Fisiológico/efectos de los fármacos , Estrés Fisiológico/genética
9.
Am J Physiol Gastrointest Liver Physiol ; 310(4): G249-61, 2016 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-26680735

RESUMEN

Apelin, an endogenous ligand for APJ receptor, has been reported to be upregulated in paraventricular nucleus (PVN) following stress. Central apelin is known to stimulate release of corticotropin-releasing factor (CRF) via APJ receptor. We tested the hypothesis that stress-induced gastrointestinal (GI) dysfunction is mediated by central apelin. We also assessed the effect of exogenous apelin on GI motility under nonstressed (NS) conditions in conscious rats. Prior to solid gastric emptying (GE) and colon transit (CT) measurements, APJ receptor antagonist F13A was centrally administered under NS conditions and following acute stress (AS), chronic homotypic stress (CHS), and chronic heterotypic stress (CHeS). Plasma corticosterone was assayed. Strain gage transducers were implanted on serosal surfaces of antrum and distal colon to record postprandial motility. Stress exposure induced coexpression of c-Fos and apelin in hypothalamic PVN. Enhanced hypothalamic apelin and CRF levels in microdialysates were detected following AS and CHeS, which were negatively and positively correlated with GE and CT, respectively. Central F13A administration abolished delayed GE and accelerated CT induced by AS and CHeS. Central apelin-13 administration increased the plasma corticosterone and inhibited GE and CT by attenuating antral and colonic contractions. The inhibitory effect elicited by apelin-13 was abolished by central pretreatment of CRF antagonist CRF9-41 in antrum, but not in distal colon. Central endogenous apelin mediates stress-induced changes in gastric and colonic motor functions through APJ receptor. The inhibitory effects of central exogenous apelin-13 on GI motility appear to be partly CRF dependent. Apelin-13 inhibits colon motor functions through a CRF-independent pathway.


Asunto(s)
Motilidad Gastrointestinal , Tracto Gastrointestinal/fisiopatología , Péptidos y Proteínas de Señalización Intercelular/metabolismo , Estrés Psicológico/metabolismo , Animales , Apelina , Receptores de Apelina , Colon/metabolismo , Corticosterona/metabolismo , Hormona Liberadora de Corticotropina/metabolismo , Vaciamiento Gástrico , Tracto Gastrointestinal/metabolismo , Tránsito Gastrointestinal , Hipotálamo/efectos de los fármacos , Hipotálamo/metabolismo , Inyecciones Intraventriculares , Péptidos y Proteínas de Señalización Intercelular/administración & dosificación , Péptidos y Proteínas de Señalización Intercelular/farmacología , Periodo Posprandial , Proteínas Proto-Oncogénicas c-fos/biosíntesis , Ratas , Ratas Wistar , Receptores Acoplados a Proteínas G/genética , Receptores Acoplados a Proteínas G/metabolismo
10.
J Surg Res ; 193(2): 626-33, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25263508

RESUMEN

BACKGROUND: Orexin-A, besides playing an important role in the mechanism of food intake, exhibits a potent gastroprotective action against the formation of acute gastric mucosal injury. The aim of the present study was to determine the effect of administered orexin-A against ischemia-reperfusion (I/R)-induced gastric injury on the expression of heme oxygenase (HO)-1 and HO-2 in gastric tissue. MATERIALS AND METHODS: Wistar rats were subjected to 30 min of ischemia followed by 3 h reperfusion. Orexin-A was infused at a dose of 500 pmol/kg/min during the I/R period. The lesion area was measured by stereomicroscope. The myeloperoxidase activity and 4-hydroxinonenol-malondialdehyde content of gastric mucosa were evaluated spectrophotometrically, and the gastric tumor necrosis factor-α was measured by enzyme linked immune sorbent assay. The expression of HO-1 and HO-2 was determined by Western blotting analysis. RESULTS: Orexin-A significantly decreased the I/R-induced gastric lesions, myeloperoxidase activity, and 4-hydroxinonenol-malondialdehyde concentration in gastric tissue exposed to I/R. The gastroprotective effect of orexin-A in gastric I/R model was accompanied by the increase in HO-2 expression and the decrease in HO-1 expression. CONCLUSIONS: Orexin-A exerts a protective action on gastric mucosa subjected to I/R, and this effect is associated with the reduction of neutrophil infiltration and lipid peroxidation in gastric tissue in addition to the increase in HO-2 expression due to the administration of orexin-A.


Asunto(s)
Hemo Oxigenasa (Desciclizante)/metabolismo , Hemo-Oxigenasa 1/metabolismo , Péptidos y Proteínas de Señalización Intracelular/farmacología , Neuropéptidos/farmacología , Neurotransmisores/farmacología , Estómago/efectos de los fármacos , Animales , Evaluación Preclínica de Medicamentos , Péptidos y Proteínas de Señalización Intracelular/uso terapéutico , Masculino , Malondialdehído/análogos & derivados , Malondialdehído/metabolismo , Neuropéptidos/uso terapéutico , Neurotransmisores/uso terapéutico , Orexinas , Peroxidasa/metabolismo , Distribución Aleatoria , Ratas Wistar , Daño por Reperfusión/prevención & control , Estómago/enzimología , Factor de Necrosis Tumoral alfa/metabolismo
11.
J Physiol Sci ; 64(4): 279-89, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24798037

RESUMEN

The aim of the present study was to investigate the gastroprotective effect of apelin on water-immersion and restraint stress (WIRS)-induced gastric lesions. Male Wistar rats were divided into four groups: control, WIRS, F13A + WIRS and F13A. APJ receptor antagonist F13A was administered to rats to determine the influence of apelin on stress-induced gastric injury. WIRS administered for 6 h resulted in the development of gastric mucosal lesions accompanied by a significant increase in plasma corticosterone. WIRS increased the concentration of 4-hydroxynonenol (4-HNE) + malondialdehyde (MDA) and the expression of apelin and hypoxia inducible factor-1α (HIF-1α) in gastric mucosa. In addition, WIRS reduced the mucosal blood flow and gastric prostaglandin E(2) (PGE(2)) concentration. Plasma corticosterone, which was increased due to stress, was significantly decreased in the F13A + WIRS group. Gastric lesions and the 4-HNE + MDA concentration were also higher in the F13A + WIRS compared to the WIRS group. We conclude that apelin has a gastroprotective effect against stress-induced lesions possibly by reducing lipid peroxidation in gastric mucosa.


Asunto(s)
Deshidratación/fisiopatología , Mucosa Gástrica/metabolismo , Péptidos y Proteínas de Señalización Intercelular/metabolismo , Restricción Física/efectos adversos , Gastropatías/metabolismo , Estrés Fisiológico/fisiología , Aldehídos/metabolismo , Animales , Apelina , Corticosterona/sangre , Corticosterona/metabolismo , Deshidratación/metabolismo , Dinoprostona/metabolismo , Mucosa Gástrica/fisiopatología , Subunidad alfa del Factor 1 Inducible por Hipoxia/metabolismo , Masculino , Malondialdehído/metabolismo , Ratas Wistar , Flujo Sanguíneo Regional/fisiología , Restricción Física/fisiología , Estómago/fisiopatología , Gastropatías/fisiopatología
12.
Cell Immunol ; 271(1): 85-8, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21741630

RESUMEN

The aim of this study was to investigate the effect of fasting-induced orexin-A (OXA) on inflammation and macrophage phagocytic activity. Fifty six male wistar rats were fasted for 36 h to stimulate OXA synthesis. In 24 rats, air pouches were induced subcutaneously in the intrascapular area. After (6 h) carrageenan injection into the pouches, the contents of the air pouches were removed. The exudate volume, protein content and cell count were measured. After the determination of fasting on inflammation, the peritoneal macrophages were collected from 32 rats to investigate the effect of fasting-induced OXA on macrophage phagocytic activity. Plasma OXA levels were markedly higher in fasted rats compared with control rats. The phagocytic capability of peritoneal macrophages was obtained as a percentage of phagocytosing macrophages and number of phagocytosed particles per cell. In spite of increased blood OXA level SB-334867, selective orexin type 1 receptor antagonist (10 mg/kg) did not change phagocytic activity of peritoneal macrophages. These findings indicate that 36 h fasting-induced OXA has no significant effect to phagocytosis of peritoneal macrophages.


Asunto(s)
Péptidos y Proteínas de Señalización Intracelular/inmunología , Macrófagos Peritoneales/inmunología , Neuropéptidos/inmunología , Fagocitosis/inmunología , Animales , Benzoxazoles/farmacología , Chondrus , Exudados y Transudados/inmunología , Exudados y Transudados/metabolismo , Ayuno/sangre , Inflamación/inducido químicamente , Inflamación/inmunología , Inflamación/metabolismo , Péptidos y Proteínas de Señalización Intracelular/sangre , Masculino , Naftiridinas , Neuropéptidos/sangre , Receptores de Orexina , Orexinas , Ratas , Ratas Wistar , Receptores Acoplados a Proteínas G/antagonistas & inhibidores , Receptores de Neuropéptido/antagonistas & inhibidores , Factores de Tiempo , Urea/análogos & derivados , Urea/farmacología
13.
Peptides ; 31(6): 1099-108, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20307611

RESUMEN

Orexin-A (OXA) and orexin receptor type 1 (OX1R) are found in enteric nervous system and smooth muscle cells in the digestive tract. Fasting is a stimulant for OXA synthesis. The aim of the present study was to investigate central and peripheral effects of endogenous OXA on gastric motility. Endogenous OXA synthesis was induced by 36h fasting. Vagotomy was used to evaluate N.vagus-mediated effects of OXA. Gastric emptying and interdigestive gastric motility were measured by spectrophotometric and manometric methods, respectively. Rats were pretreated with OX1R antagonist SB-334867 prior to measurements. Plasma OXA concentration was assayed with radioimmunoassay while preproorexin (PPO) expression was determined with Western blotting in gastric and hypothalamic tissues. OXA immunoreactivity in antrum was determined with immunohistochemistry. Plasma OXA level, PPO protein expression and OXA immunoreactivity were significantly increased in response to 36h fasting. Endogenous OXA facilitated gastric emptying and inhibited gastric interdigestive motility. As these effects were abolished with SB-334867, it is likely that gastrokinetic effects of OXA are mediated via OX1R. Vagotomy did not alter OXA-mediated effects. According to current data, OXA is up-regulated both centrally and peripherally upon fasting. Endogenous OXA accelerates gastric emptying while it inhibits interdigestive motility.


Asunto(s)
Vaciamiento Gástrico/efectos de los fármacos , Péptidos y Proteínas de Señalización Intracelular/fisiología , Neuropéptidos/fisiología , Animales , Benzoxazoles/farmacología , Ayuno/fisiología , Motilidad Gastrointestinal/efectos de los fármacos , Péptidos y Proteínas de Señalización Intracelular/sangre , Masculino , Naftiridinas , Neuropéptidos/biosíntesis , Neuropéptidos/sangre , Receptores de Orexina , Orexinas , Ratas , Receptores Acoplados a Proteínas G/antagonistas & inhibidores , Receptores de Neuropéptido/antagonistas & inhibidores , Regulación hacia Arriba , Urea/análogos & derivados , Urea/farmacología , Nervio Vago/fisiología
14.
J Surg Res ; 161(1): 126-33, 2010 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-19959193

RESUMEN

BACKGROUND: Angiotensin II contributes to the pathogenesis of inflammation induced by ischemia-reperfusion (I/R) in various organs. Angiotensin II increases vascular permeability that initiates the inflammatory process and leads to the migration of inflammatory cells into the tissue. The aim of the present study was to investigate the effect of angiotensin II on ischemia-reperfusion induced expressions of inducible NO synthase (iNOS) and cyclooxygenase-2 (COX-2) in rat stomachs exposed to ischemia-reperfusion. METHODS: Wistar rats were randomly separated into five groups: sham operated, I/R, I/R plus candesartan (an AT1 receptor antagonist), I/R plus PD123319 (an AT2 receptor antagonist), and I/R plus captopril (an angiotensin-converting enzyme inhibitor). Candesartan (1mg/kg/d), PD123319 (3mg/kg/d), and captopril (20mg/kg/d) were given subcutaneously twice a day for 5 d before I/R. The rats were submitted to gastric ischemia by clamping the celiac artery for 30min followed by 24h reperfusion. RESULTS: Candesartan decreased the neutrophil accumulation, iNOS expression, and increased NOx level, COX-2 expression in the gastric tissue exposed to I/R compared with I/R group. PD123319 did not change the neutrophil accumulation, iNOS expression, PGE(2), or NOx levels, but increased the expression of COX-2 in the gastric tissue exposed to I/R. However, captopril did not play any role in I/R induced change in gastric mucosa. CONCLUSIONS: The results suggest that Angiotensin II via angiotensin II type 1 receptor increases the accumulation of neutrophils and iNOS expression and plays a significant role in mediating inflammation in gastric mucosa exposed to I/R.


Asunto(s)
Angiotensina II/sangre , Ciclooxigenasa 2/metabolismo , Gastritis/enzimología , Óxido Nítrico Sintasa de Tipo II/metabolismo , Daño por Reperfusión/enzimología , Bloqueadores del Receptor Tipo 1 de Angiotensina II/farmacología , Bloqueadores del Receptor Tipo 2 de Angiotensina II , Inhibidores de la Enzima Convertidora de Angiotensina/farmacología , Animales , Bencimidazoles/farmacología , Compuestos de Bifenilo , Captopril/farmacología , Dinoprostona/metabolismo , Gastritis/etiología , Imidazoles/farmacología , Masculino , Neutrófilos/metabolismo , Óxido Nítrico/metabolismo , Peroxidasa/metabolismo , Piridinas/farmacología , Ratas , Ratas Wistar , Daño por Reperfusión/complicaciones , Tetrazoles/farmacología
15.
J Gastroenterol ; 43(3): 202-7, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18373162

RESUMEN

BACKGROUND: Orexins are involved in the regulation of sleeping behavior and energy homeostasis, and they are also implicated in the regulation of gastrointestinal functions. Previous reports have demonstrated the expression of orexin receptors in the gastrointestinal system. The aim of this study was to investigate the gastroprotective effect of orexin-A in ischemia-reperfusion-induced gastric mucosal injury. METHODS: The gastric ischemia-reperfusion model was established by clamping the celiac artery for 30 min and reperfusing for 60 min. Orexin-A was administered in doses of 500 pmol.kg(-1).min(-1) by infusion throughout the ischemia-reperfusion period. The mean lesion area, gastric prostaglandin E2 and mucus content, myeloperoxidase activity, and production of thiobarbituric acid reactive substances were measured. RESULTS: Orexin-A significantly attenuated the ischemia-reperfusion-induced gastric lesions and also decreased myeloperoxidase activity and the thiobarbituric acid reactive substances content in gastric mucosa of rats exposed to ischemia-reperfusion. However, the decline in gastric prostaglandin E2 and mucus content was not restored by orexin-A treatment. CONCLUSIONS: Orexin-A exhibited a gastroprotective effect against ischemia-reperfusion-induced lesions by decreasing neutrophil activation and lipid peroxidation.


Asunto(s)
Mucosa Gástrica/efectos de los fármacos , Péptidos y Proteínas de Señalización Intracelular/farmacología , Neuropéptidos/farmacología , Neurotransmisores/farmacología , Daño por Reperfusión/prevención & control , Animales , Dinoprostona/metabolismo , Femenino , Mucosa Gástrica/patología , Peroxidación de Lípido/efectos de los fármacos , Moco/efectos de los fármacos , Moco/metabolismo , Activación Neutrófila/efectos de los fármacos , Orexinas , Peroxidasa/efectos de los fármacos , Peroxidasa/metabolismo , Ratas , Ratas Wistar , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo
16.
Immunobiology ; 212(7): 583-7, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17678716

RESUMEN

Docosahexaenoic acid (DHA) is an omega-3 fatty acid which has been demonstrated to exhibit anti-inflammatory effects. The objective of this study was to determine the effect of DHA on phagocytic and chemotactic activities of peritoneal macrophages obtained from rats. DHA was dissolved in 1 ml of corn oil at dose of 36 mg/kg/day and given via oral gavage for 4 weeks. Control rats received 1 ml/day corn oil as vehicle. At the end of the treatment period, peritoneal macrophages were isolated and chemotactic and phagocytic activities were assayed. Chemotactic and phagocytic activities were reduced in rats fed with DHA. These results demonstrated the effect of DHA in modulating immune activities of rat peritoneal macrophages.


Asunto(s)
Quimiotaxis/efectos de los fármacos , Ácidos Docosahexaenoicos/farmacología , Macrófagos Peritoneales/efectos de los fármacos , Macrófagos Peritoneales/inmunología , Fagocitosis/efectos de los fármacos , Animales , Ácidos Docosahexaenoicos/administración & dosificación , Masculino , Ratas , Ratas Wistar
17.
J Physiol Sci ; 57(3): 187-92, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17547782

RESUMEN

BACKGROUND AND AIM: L-Carnitine is an essential cofactor in the mitochondrial transfer of fatty acids, and it is also a scavenger of free radicals in mammalian tissues. The aim of the study was to determine the effect of L-carnitine on chronic restraint stress-induced gastric mucosal injury. METHODS: Wistar rats were applied restraint stress (1 h/day) and L-carnitine (50 mg/kg) for 21 days. The lesion index, prostaglandin E(2) and mucus content, lipid peroxidation, superoxide dismutase, and catalase activity in gastric mucosa were evaluated. RESULTS: Chronic restraint stress increased the lesion index, lipid peroxidation, and superoxide dismutase activity in gastric mucosa, and it decreased prostaglandin E(2) and mucus content. L-Carnitine treatment prevented the stress-induced increase in lesion index, lipid peroxidation and a stress-induced decline in prostaglandin E(2), and mucus content in gastric mucosa, but it increased catalase activity. CONCLUSIONS: L-Carnitine prevents the occurrence of lesion by strengthening the gastric mucosal barrier and by reducing lipid peroxidation against the harmful effects of chronic restraint stress.


Asunto(s)
Carnitina/farmacocinética , Estómago/efectos de los fármacos , Estrés Fisiológico/metabolismo , Animales , Carnitina/administración & dosificación , Catalasa/efectos de los fármacos , Catalasa/metabolismo , Dinoprostona/metabolismo , Mucosa Gástrica/lesiones , Mucosa Gástrica/metabolismo , Mucosa Gástrica/patología , Glicosaminoglicanos/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Masculino , Ratas , Ratas Wistar , Restricción Física , Estómago/lesiones , Estómago/patología , Úlcera Gástrica/inducido químicamente , Úlcera Gástrica/tratamiento farmacológico , Úlcera Gástrica/metabolismo , Estrés Fisiológico/patología , Superóxido Dismutasa/efectos de los fármacos , Superóxido Dismutasa/metabolismo
18.
Clin Exp Pharmacol Physiol ; 33(10): 946-51, 2006 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17002672

RESUMEN

The aim of the present study was to determine the role of prostaglandins (PG), nitric oxide (NO) and capsaicin-sensitive sensory nerves in neutrophil infiltration in gastric adaptation to cold restraint stress in rats. Wistar rats were exposed to single or repeated cold restraint stress for 3.5 h every other day for up to 4 days. Prior to repeated stress, rats were pretreated with NG-nitro-L-arginine methyl ester (L-NAME; 10 mg/kg, s.c.), indomethacin (10 mg/kg, s.c.) or capsaicin (125 mg/kg, s.c.). The extent of gastric mucosal lesions was evaluated histologically and myeloproxidase (MPO) activity, PGE2, NO and calcitonin gene-related peptide (CGRP) levels were measured in gastric tissue. Cold restraint stress produced haemorrhagic lesions and reduced PGE2 and CGRP levels in the stomach, with an increase in MPO activity and NO levels. Repeated stress insults reduced stress-induced gastric damage, NO production and MPO activity, with an increase in PGE2 and CGRP levels compared with rats exposed to single cold restraint stress. Adaptation to cold restraint stress was prevented by indomethacin and capsaicin pretreatment, but not by L-NAME. We conclude that the stomach has the ability to adapt to repeated exposure to cold restraint stress and that the adaptation, via inhibition of neutrophil infiltration, is mediated, at least in part, by endogenous PG and CGRP.


Asunto(s)
Aclimatación/efectos de los fármacos , Capsaicina/farmacología , Neuronas Aferentes/efectos de los fármacos , Infiltración Neutrófila/efectos de los fármacos , Óxido Nítrico/fisiología , Prostaglandinas/fisiología , Estómago/patología , Estrés Fisiológico , Animales , Péptido Relacionado con Gen de Calcitonina/metabolismo , Frío/efectos adversos , Dinoprostona/metabolismo , Mucosa Gástrica/efectos de los fármacos , Mucosa Gástrica/metabolismo , Indometacina/farmacología , Masculino , NG-Nitroarginina Metil Éster/farmacología , Óxido Nítrico/metabolismo , Peroxidasa/metabolismo , Ratas , Ratas Wistar , Restricción Física/efectos adversos , Restricción Física/métodos , Úlcera Gástrica/inducido químicamente , Estrés Fisiológico/patología , Sensación Térmica/efectos de los fármacos
19.
Cell Biochem Funct ; 24(5): 437-42, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16130180

RESUMEN

Reactive oxygen metabolites play an important role in ischemia-reperfusion related gastric injury. Primary sources of reactive oxygen metabolites seem to be the xanthine/xanthine oxidase system and neutrophils accumulating within the reperfused tissue. Tissue myeloperoxidase activity is an important index of neutrophil accumulation. The purpose of the present study was to clarify the effect of L-carnitine on the accumulation of neutrophils and neutrophil-induced gastric mucosal damage in rats exposed to ischemia-reperfusion. Rats were randomly divided into three groups: sham-operated, ischemia-reperfusion and ischemia-reperfusion plus L-carnitine groups. Ischemia was induced by clamping the celiac artery for 30 min and then reperfusion was established for 60 min. Gastric injury was assessed by measuring myeloperoxidase activity in gastric tissue. The neutrophil accumulation and hemorrhagic lesions due to ischemia-reperfusion in gastric mucosa were ascertained in a histological study. L-Carnitine (100 mg kg(-1)) administrated intravenously 5 min before ischemia significantly reduced both the gastric injury and myeloperoxidase activity compared with the ischemia-reperfusion group. The results suggest that L-carnitine provides marked protection against ischemia-reperfusion-related gastric injury which could be due to its ability to reduce neutrophil accumulation in ischemic tissue.


Asunto(s)
Carnitina/farmacología , Mucosa Gástrica/patología , Neutrófilos/patología , Daño por Reperfusión/tratamiento farmacológico , Complejo Vitamínico B/farmacología , Enfermedad Aguda , Animales , Mucosa Gástrica/metabolismo , Masculino , Neutrófilos/metabolismo , Peroxidasa/metabolismo , Ratas , Ratas Wistar , Especies Reactivas de Oxígeno/metabolismo , Daño por Reperfusión/metabolismo , Daño por Reperfusión/patología
20.
Food Chem Toxicol ; 43(4): 599-605, 2005 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15721208

RESUMEN

Sulfite has both an endogenous and an exogenous provenance in the mammalian tissues. The aim of the present study was to assess the effect of sulfite on macrophages functions in normal or sulfite oxidase deficient rats. Rats were divided into eight groups; (1) control group, (2) sulfite group (the rats received sodium meta bi-sulfite (25 mg/kg) in drinking water for 6 weeks), (3) vitamin E group (the rats received Vit E (50 mg/kg) by gavage for 6 weeks), (4) sulfite group+Vit E, (5)sulfite oxidase deficient group (the rats received high-W/Mo-deficient diet. The activity of sulfite oxidase was reduced in rats maintained on the high-W/Mo-deficient diet during the first 21 days of treatment. After the sulfite-oxidase deficiency, the rats continued to receive high-W/Mo-deficient diet for 6 weeks.), (6) sulfite+sulfite oxidase deficient group, (7) Vit E+sulfite oxidase deficient group, and (8) sulfite+Vit E+sulfite oxidase deficient group. Sulfite caused a significant increase in phagocytic and chemotactic activities of peritoneal macrophages. In sulfite-oxidase deficient rats, the increase in phagocytic and chemotactic activities in peritoneal macrophages after sulfite intake was found more than the control rats. Vit E supplementation prevented sulfite induced increase in macrophages functions. These results show that the macrophage functions are sensitive to sulfite intake. The effect of sulfite on macrophage functions may be related to reactive oxygen species. Because Vit E administration was able to modulate significantly sulfite-induced changes in the functions of peritoneal macrophages.


Asunto(s)
Broncoconstrictores/farmacología , Macrófagos/efectos de los fármacos , Macrófagos/fisiología , Oxidorreductasas actuantes sobre Donantes de Grupos Sulfuro/farmacología , Sulfitos/farmacología , Animales , Antioxidantes/farmacología , Quimiotaxis/efectos de los fármacos , Masculino , Oxidorreductasas actuantes sobre Donantes de Grupos Sulfuro/genética , Fagocitosis/efectos de los fármacos , Ratas , Ratas Wistar , Vitamina E/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...